InvestorsHub Logo
Followers 8
Posts 328
Boards Moderated 0
Alias Born 01/11/2014

Re: goodJohnhunting post# 3572

Saturday, 09/06/2014 6:22:48 PM

Saturday, September 06, 2014 6:22:48 PM

Post# of 34577
Since Galena had a successful Phase 2 result which prompted a Phase 3 test, I have to believe that with better epitopes, TapImmune will also have a successful Phase 2 that will lead to Phase 3.

Also, Merck's success with Keytruda will definitely put immunotherapy into the spotlight which only helps TapImmune find more investors. Didn't they talk about immunotherapy during that Cancer broadcast special on tv last night? I didn't see it but someone mentioned that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News